Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 12, 16:00
Forte Biosciences Total Return Level : 76.99 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 76.99 |
| October 09, 2026 | 76.99 |
| October 08, 2026 | 76.99 |
| October 07, 2026 | 76.99 |
| October 06, 2026 | 76.99 |
| October 05, 2026 | 76.99 |
| October 02, 2026 | 76.99 |
| October 01, 2026 | 76.99 |
| September 30, 2026 | 76.99 |
| September 29, 2026 | 76.99 |
| September 28, 2026 | 76.99 |
| September 25, 2026 | 76.99 |
| September 24, 2026 | 76.99 |
| September 23, 2026 | 76.99 |
| September 22, 2026 | 76.99 |
| September 21, 2026 | 76.99 |
| September 18, 2026 | 76.99 |
| September 17, 2026 | 76.99 |
| September 16, 2026 | 76.99 |
| September 15, 2026 | 76.99 |
| September 14, 2026 | 76.99 |
| September 11, 2026 | 76.99 |
| September 10, 2026 | 76.99 |
| September 09, 2026 | 76.99 |
| September 08, 2026 | 76.99 |
| Date | Value |
|---|---|
| September 04, 2026 | 76.99 |
| September 03, 2026 | 76.99 |
| September 02, 2026 | 76.99 |
| September 01, 2026 | 76.99 |
| August 31, 2026 | 76.99 |
| August 28, 2026 | 76.99 |
| August 27, 2026 | 76.99 |
| August 26, 2026 | 76.99 |
| August 25, 2026 | 76.97 |
| August 24, 2026 | 76.95 |
| August 21, 2026 | 76.92 |
| August 20, 2026 | 76.89 |
| August 19, 2026 | 76.90 |
| August 18, 2026 | 76.88 |
| August 17, 2026 | 76.89 |
| August 14, 2026 | 76.83 |
| August 13, 2026 | 76.86 |
| August 12, 2026 | 76.78 |
| August 11, 2026 | 76.87 |
| August 10, 2026 | 76.82 |
| August 07, 2026 | 76.79 |
| August 06, 2026 | 76.83 |
| August 05, 2026 | 76.61 |
| August 04, 2026 | 76.56 |
| August 03, 2026 | 76.61 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| argenx SE | 812.30 |
| ACADIA Pharmaceuticals, Inc. | 19.41 |
| Alnylam Pharmaceuticals, Inc. | 227.02 |
| Anika Therapeutics, Inc. | 20.47 |
| Savara, Inc. | 4.84 |